Zentalis Pharmaceuticals, Inc. (ZNTL)
NY
Total Compensation for Fiscal Year Ending in 2023: $12,853,590
Salary | $701,425 |
---|---|
Bonus | $0 |
Value of Stock Awards | $5,789,520 |
Value of Option Awards | $5,890,563 |
Non-Equity Incentive Plan Compensation | $455,000 |
Change in Pension Value and Deferred Compensation Earnings | $0 |
All Other Compensation | $17,082 |
Total | $12,853,590 |
Zentalis Pharmaceuticals, Inc. disclosed its CEO pay was
44
times its median employee's pay for the fiscal year ending in 2023.
How Do You Compare?